Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
NVIDIA
NVDA
|
$8.86B |
| 2 |
e.l.f. Beauty
ELF
|
$802M |
| 3 |
UnitedHealth
UNH
|
$418M |
| 4 |
AutoZone
AZO
|
$344M |
| 5 |
Kaspi.kz JSC
KSPI
|
$283M |
Top Sells
| 1 |
Spotify
SPOT
|
$1.68B |
| 2 |
Tesla
TSLA
|
$701M |
| 3 |
Teradyne
TER
|
$630M |
| 4 |
Shopify
SHOP
|
$406M |
| 5 |
Moody's
MCO
|
$335M |
Sector Composition
| 1 | Consumer Discretionary | 29.2% |
| 2 | Technology | 27.92% |
| 3 | Communication Services | 14.16% |
| 4 | Healthcare | 13.89% |
| 5 | Financials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Axon Enterprise
AXON
$56.2B
| $69.3M | 0.05% |
235,469
-79,268
| -25% | -$23.3M |
|
127
MarketAxess Holdings
MKTX
$6.75B
| $69M | 0.05% |
344,001
-73,059
| -18% | -$14.7M |
|
128
Lemonade
LMND
$3.77B
| $67M | 0.05% |
4,061,391
-407,593
| -9% | -$6.73M |
|
129
AbCellera Biologics
ABCL
$1.2B
| $64.9M | 0.05% |
21,911,014
-1,269,075
| -5% | -$3.76M |
|
|
JMIA
130
Jumia Technologies
JMIA
$970M
| $63.9M | 0.05% |
9,106,406
-29,502
| -0.3% | -$207K |
|
131
Zillow
Z
$20.4B
| $61.3M | 0.05% |
1,321,122
-295,280
| -18% | -$13.7M |
|
132
Cognex
CGNX
$7.34B
| $60.7M | 0.05% |
1,299,175
+134,833
| +12% | +$6.3M |
|
133
Banco de Chile
BCH
$14.8B
| $60.5M | 0.05% |
+2,671,779
| New | +$60.5M |
|
134
Exact Sciences
EXAS
$9.14B
| $60.3M | 0.05% |
1,426,617
-275,371
| -16% | -$11.6M |
|
135
Sana Biotechnology
SANA
$729M
| $57.7M | 0.05% |
10,571,200
-85,079
| -0.8% | -$465K |
|
136
Infosys
INFY
$68.7B
| $55M | 0.04% |
2,953,147
+111,032
| +4% | +$2.07M |
|
137
Coca-Cola
KO
$292B
| $54.5M | 0.04% |
856,517
+50,022
| +6% | +$3.18M |
|
138
10x Genomics
TXG
$1.67B
| $53.3M | 0.04% |
2,742,153
-4,682,613
| -63% | -$91.1M |
|
139
Itaú Unibanco
ITUB
$74.6B
| $53.3M | 0.04% |
9,125,793
-99,972
| -1% | -$584K |
|
140
Cisco
CSCO
$267B
| $51.9M | 0.04% |
1,092,004
+28,526
| +3% | +$1.36M |
|
141
American Superconductor
AMSC
$2.22B
| $51.8M | 0.04% |
2,214,083
-312,467
| -12% | -$7.31M |
|
142
Twist Bioscience
TWST
$1.6B
| $48.5M | 0.04% |
984,302
-243,226
| -20% | -$12M |
|
143
JFrog
FROG
$5.5B
| $47.8M | 0.04% |
1,274,163
-182,659
| -13% | -$6.86M |
|
144
T Rowe Price
TROW
$23.1B
| $45.4M | 0.04% |
393,301
+31,290
| +9% | +$3.61M |
|
145
Ginkgo Bioworks
DNA
$663M
| $44.9M | 0.04% |
134,425,866
-98,573,807
| -42% | -$33M |
|
146
Appian
APPN
$2.28B
| $44.6M | 0.03% |
1,443,767
-312,652
| -18% | -$9.65M |
|
147
SolarEdge
SEDG
$2.01B
| $43.5M | 0.03% |
1,722,886
-10,774
| -0.6% | -$272K |
|
148
LiveRamp
RAMP
$1.79B
| $43.2M | 0.03% |
1,396,913
-235,920
| -14% | -$7.3M |
|
149
Schrodinger
SDGR
$1.41B
| $41.1M | 0.03% |
2,124,968
-487,039
| -19% | -$9.42M |
|
150
New York Times
NYT
$9.58B
| $40.3M | 0.03% |
787,171
-35,968
| -4% | -$1.84M |
|